$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
勃林格殷格翰的思力华哪里有卖?
2025-10-19 11:44:20
Check Details
勃林格殷格翰的思力华好用吗?
2025-10-19 11:44:20
Check Details
勃林格殷格翰的思力华如何购买?
2025-10-19 11:44:20
Check Details
勃林格殷格翰的思力华的效果怎么样?
2025-10-19 11:44:20
Check Details
勃林格殷格翰的思力华一盒多少钱?
2025-10-19 11:44:20
Check Details
勃林格殷格翰能倍乐使用方法
2025-10-19 11:44:20
Check Details
勃林格殷格翰能倍乐进入医保了吗?
2025-10-19 11:44:20
Check Details
勃林格殷格翰能倍乐使用说明书
2025-10-19 11:44:20
Check Details
勃林格殷格翰能倍乐在哪里买?
2025-10-19 11:44:20
Check Details
勃林格殷格翰能倍乐最大使用量
2025-10-19 11:44:20
Check Details
勃林格殷格翰能倍乐如何购买?
2025-10-19 11:44:20
Check Details
德国勃林格殷格翰能倍乐图片及介绍
2025-10-19 11:44:20
Check Details
1
2
...
3429
3430
3431
3432
3433
3434
3435
...
10230
10231
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Selpercatinib: Dosing and Administration Essentials of an Oral RET Inhibitor
2
Enasidenib: A Targeted IDH2 Inhibitor for Acute Myeloid Leukemia
3
Alpelisib: From Breast Cancer to PIK3CA-Related Overgrowth Spectrum
4
Ponatinib in Chronic Myeloid Leukemia: 5-Year Results from the OPTIC Trial
5
Erdafitinib Oral Tablets: Strengths, Packaging, and Dose Adjustment
6
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
7
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC
8
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
9
Lapatinib: An Oral Dual EGFR/HER2 TKI in HER2-Positive Breast Cancer
10
Filgotinib (Jyseleca) Overseas Guide: JAK1 Inhibitor for Rheumatoid Arthritis and Ulcerative Colitis
11
FDA Approves LISRAYA (brepocitinib): First Oral Targeted Therapy for Adults with Dermatomyositis
12
Elagolix for Endometriosis Pain: Indications and Usage Guidelines